FDA Memo Links 10 Child Deaths to COVID Vaccines
An internal FDA review linked 10 child deaths to COVID-19 vaccines, citing myocarditis; findings have not been peer-reviewed and precede a CDC vaccine committee meeting.
- The FDA's top vaccine regulator has proposed tightening standards for how vaccines win federal approval after an internal safety review found at least 10 child deaths were vaccine related.
- Under the proposed framework, manufacturers would need larger trials that prove real-world protection, not only antibody responses, and must show reductions in diseases like pneumonia, not just immune markers.
- Some current and former FDA staffers warned the overhaul could dramatically lengthen timelines and discourage new vaccine projects by requiring larger, longer trials for each eligible population.
96 Articles
96 Articles
FDA Internal Memo Links Child Deaths to COVID-19 Vaccination
An internal Food and Drug Administration (FDA) memo obtained by The Epoch Times reveals that career scientists in the agency’s vaccine-safety offices have identified “no fewer than 10” child deaths they consider related to COVID-19 vaccination. The Nov. 28 memo, written by Dr. Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER), marks what Prasad calls the first acknowledgment inside the agency that the vaccin…
FDA Chief Medical Officer Demands ‘Introspection’ by Staff After Report Tracing 10 Children’s Deaths to COVID Vaccine
DAILY CALLER NEWS FOUNDATION—A top Food and Drug Administration (FDA) official called for introspection, humility and transformation at the agency in an email obtained by the Daily Caller News Foundation (DCNF) following a report by career staff that the deaths of 10 children may be attributed to the COVID-19 vaccine. “At least 10 children have died after and because of receiving COVID-19 vaccination,” FDA Chief Medical Officer and Center for Bi…
FDA’s Prasad Cites Alleged Child COVID Shot Deaths in Push for Stricter Rules FDA’s Prasad Cites Alleged Child COVID Shot Deaths in Push for Stricter Rules - Moderna (NASDAQ:MRNA), Pfizer (NYSE:PFE)
FDA's new vaccine strategy tightens approval rules after internal findings linked COVID-19 shots to several child deaths.
Coverage Details
Bias Distribution
- 36% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium



































